Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A novel multicompartment barrier-free microfluidic device reveals the impact of extracellular matrix stiffening and temozolomide on immune-tumor interactions in glioblastoma

  • Bayona, Clara
  • Olaizola-Rodrigo, Claudia
  • Sharko, Vira
  • Ashrafi, Mehran
  • Barrio, Jesús del
  • Doblaré, Manuel
  • Monge, Rosa
  • Ochoa, Ignacio
  • Oliván, Montserrat
The immune system plays a crucial role in shaping the glioblastoma tumor microenvironment, characterized by its complexity and dynamic interactions. Understanding the tumor-immune crosstalk is essential for advancing cancer research and therapeutic development. Here, a novel multicompartment, barrier-free microfluidic device is presented that overcomes the limitations of existing models by enabling direct tumor-immune interactions without physical barriers, preserving natural immune cell infiltration. This platform supports the independent and simultaneous culture of tumor and immune cells, replicating the healthy-tumoral stroma interface, and allows investigating the effect of matrix stiffness and chemotherapy on both populations. The findings reveal that increased collagen concentration promotes tumor invasiveness while impairing immune cell infiltration. Additionally, temozolomide treatment reduces immune cell motility but enhances anti-tumor immune responses. These insights highlight the critical roles of extracellular matrix mechanics and chemotherapy in tumor progression and immune modulation, establishing this device as a powerful tool for studying glioblastoma-immune dynamics and evaluating therapeutic strategies., This work was supported by the Ministry of Science and Innovation, the Agency and the European Regional Development Fund (Project PID2021-126051OB-C41 funded by MCIN /AEI /10.13039/501100011033 / FEDER, UE). This work was supported by the Chips Joint Undertaking (Grant Agreement No. 101140192) and MICIU/AEI/10.13039/501100011033 (PCI2024-153531). This work received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI). Beonchip S.L. would like to acknowledge the financial support received from the Plan de Recuperación, Transformación y Resiliencia. Authors would like to acknowledge the use of Servicio General de Apoyo a la Investigación-SAI, Universidad de Zaragoza and the collaboration of the Plataforma de Apoyo Preclínico (PAP) at the Aragon Health Research Institute (IISA). The authors also thank the patients and the Biobank of the Aragon Health System (PT23/00146) integrated in the Platform ISCIII Biobanks and Biomodels for their collaboration. The authors acknowledge the use of BioRender for generating high-quality scientific illustrations. C.O.R. would like to acknowledge the financial support received from the Spanish Government through a research grant provided by the MINECO fellowship (DIN 2020–011544). C.B. and V.S. would like to thank Gobierno de Aragón (DGA) for the predoctoral funding. The authors thank Gobierno de Aragón and Fondo Social Europeo for the financial help given to TME lab group T62_23R., Peer reviewed